RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
High specific activity (+)-amphetamine and (+)-methamphetamine
Lamb, P., McElhinny, C., Sninski, T., Purdom, H., Carroll, F., & Lewin, A. (2009). High specific activity (+)-amphetamine and (+)-methamphetamine. Journal of Labelled Compounds and Radiopharmaceuticals, 52(11), 457-462. https://doi.org/10.1002/jlcr.1659
High specific activity (+)-amphetamine and (+)-methamphetamine were prepared by reductive dechlorination of (S)-(3,5-dichlorophenyl)-2-propylazide and (S)-26-dichloromethamphetamine, respectively. While the latter was readily obtained by resolution of racemic 26-dichloromethamphetamine using (+)-dibenzoyltartaric acid, the analogous amphetamine resisted all efforts to resolve it. Hence, the required chiral precursor was prepared by stereospecific total synthesis following methodology that had been previously developed in our Laboratories. The tritium labeled compounds had specific activity 30.1 Ci/mmol and 38.3 Ci/mmol, respectively.